Management of Major Depression in the Workplace

[1]  H. Birnbaum,et al.  The impact of antidepressant use on social functioning: reboxetine versus fluoxetine , 2000, International clinical psychopharmacology.

[2]  R. Kessler,et al.  Depression in the workplace: effects on short-term disability. , 1999, Health affairs.

[3]  A. Claxton,et al.  Absenteeism among employees treated for depression. , 1999, Journal of occupational and environmental medicine.

[4]  J. Russell,et al.  Course and cost of treatment for depression with fluoxetine, paroxetine, and sertraline. , 1999, The American journal of managed care.

[5]  J. Russell,et al.  Depression in the Workplace , 1998 .

[6]  G. Simon,et al.  Health care costs of primary care patients with recognized depression. , 1995, Archives of general psychiatry.

[7]  R. Kessler,et al.  The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. , 1994, The American journal of psychiatry.

[8]  E. Berndt,et al.  The economic burden of depression in 1990. , 1993, The Journal of clinical psychiatry.

[9]  D. Blazer,et al.  The economic burden of depression. , 1986, General hospital psychiatry.

[10]  R. Cadoret,et al.  Anorexia nervosa in a 45-year-old man. , 1984, The Journal of clinical psychiatry.

[11]  R. Kessler,et al.  Past-year use of outpatient services for psychiatric problems in the National Comorbidity Survey. , 1999, The American journal of psychiatry.

[12]  E. Berndt,et al.  Measuring Prices and Quantities of Treatment for Depression , 1998 .

[13]  W. Burton,et al.  Use of an Integrated Health Data Warehouse to Measure the Employer Costs of Five Chronic Disease States , 1998 .

[14]  D. Healy,et al.  The enhancement of social functioning as a therapeutic principle in the management of depression. , 1997, Journal of psychopharmacology.